Table 2.
Relationship between ovarian metastasis and other clinicopathologic characteristics in stage IB cervical adenocarcinoma.
| Risk factors | Numbers | Ovarian metastasis | P | |
|---|---|---|---|---|
| Negative | Positive | |||
| Age (years) | ||||
| ≤45 | 52 (59.1%) | 50 | 2 | 1.00 |
| >45 | 36 (40.9%) | 34 | 2 | |
| Satge (FIGO 2009) | ||||
| IB1 | 51 (57.95%) | 50 | 1 | 0.305 |
| IB2 | 37 (42.05%) | 34 | 3 | |
| Grade | ||||
| G1 | 42 (47.7%) | 42 | 0 | 0.067 |
| G2 | 21 (23.9%) | 19 | 2 | |
| G3 | 25 (28.4%) | 23 | 2 | |
| Tumor size (cm) | ||||
| ≤2 | 36 (40.9%) | 36 | 0 | 0.112 |
| >2, <4 | 15 (17.0%) | 14 | 1 | |
| ≥4 | 37 (42.1%) | 34 | 3 | |
| LSVI | ||||
| Positive | 22 (25%) | 19 | 3 | 0.047 |
| Negative | 66 (75%) | 65 | 1 | |
| Lymph node status | ||||
| Positive | 17 (19.3%) | 14 | 3 | 0.022 |
| Negative | 71 (80.7%) | 70 | 1 | |
| Stromal invasion | ||||
| <1/2 | 55 (62.5%) | 55 | 0 | 0.018 |
| >1/2 | 33 (37.5%) | 29 | 4 | |
| Parametrial involvement | ||||
| Positive | 7 (7.95%) | 6 | 1 | 0.287 |
| Negative | 81 (92.05%) | 78 | 3 | |
| Involvement of the the junction of the cervix and uterus body | ||||
| Positive | 16 (18.2%) | 13 | 3 | 0.018 |
| Negative | 72 (81.8%) | 71 | 1 | |
| Involvement of the uterus body | ||||
| Positive | 5 (5.7%) | 5 | 0 | 1.00 |
| Negative | 83 (94.3%) | 79 | 4 | |
| Vaginal involvement | ||||
| Positive | 3 (3.4%) | 3 | 0 | 1.00 |
| Negative | 8 5(96.6%) | 81 | 4 | |
| SCCA | 88 | 0.48±051 | 0.30±0.25 | 0.254 |
| CA125 | 88 | 36.52±85.67 | 57.05±52.39 | 0.503 |